摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(dansylamino)hexyl]aminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol | 1320341-35-2

中文名称
——
中文别名
——
英文名称
N-[(dansylamino)hexyl]aminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol
英文别名
N-[6-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]hexyl]-6-[(2R,3S,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexanamide
N-[(dansylamino)hexyl]aminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol化学式
CAS
1320341-35-2
化学式
C30H48N4O7S
mdl
——
分子量
608.8
InChiKey
FFECDIPLJGSHMF-MOXFVITDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    42
  • 可旋转键数:
    17
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    171
  • 氢给体数:
    6
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (6-甲氧基-6-氧代己基)胺盐酸甲醇 、 20% palladium(II) hydroxide on carbon 、 氢气 、 sodium hydroxide 作用下, 以 甲醇二氯甲烷 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 75.0h, 生成 N-[(dansylamino)hexyl]aminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol
    参考文献:
    名称:
    1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
    摘要:
    Two simple and reliably accessible intermediates, N-carboxypentyl- and N-aminohexyl-1-deoxy-D-galactonojirimycin were employed for the synthesis of a set of terminally N-dansyl substituted derivatives. Reaction of the terminal carboxylic acid of N-carboxypentyl-1-deoxy-D-galactonojirimycin with N-dansyl-1,6-diaminohexane provided the chain-extended fluorescent derivative. Employing bis(6-dansylaminohexyl)amine, the corresponding branched di-N-dansyl compound was obtained. Partially protected N-aminohexyl-1-deoxy-D-galactonojirimycin served as intermediate for two additional chain-extended fluorescent 1-deoxy-D-galactonojirimycin (1-DGJ) derivatives featuring terminal dansyl groups in the N-alkyl substituent. These new compounds are strong inhibitors of D-galactosidases and may serve as leads en route to pharmacological chaperones for GM1-gangliosidosis. (C) 2011 Published by Elsevier Ltd.
    DOI:
    10.1016/j.carres.2011.05.010
点击查看最新优质反应信息

文献信息

  • A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-d-galactitol
    作者:Richard F.G. Fröhlich、Katrin Fantur、Richard H. Furneaux、Eduard Paschke、Arnold E. Stütz、Jacqueline Wicki、Stephen G. Withers、Tanja M. Wrodnigg
    DOI:10.1016/j.bmcl.2011.09.012
    日期:2011.11
    N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol, a strong competitive inhibitor of beta-galactosidase, enhances residual beta-galactosidase activities in fibroblasts and serves as lead en route to diagnostic compounds for tracking the fate of mutant beta-gal as well as aberrant GM1 gangliosides by live cell imaging. (C) 2011 Elsevier Ltd. All rights reserved.
  • 1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
    作者:Richard F.G. Fröhlich、Richard H. Furneaux、Don J. Mahuran、Robert Saf、Arnold E. Stütz、Michael B. Tropak、Jacqueline Wicki、Stephen G. Withers、Tanja M. Wrodnigg
    DOI:10.1016/j.carres.2011.05.010
    日期:2011.9
    Two simple and reliably accessible intermediates, N-carboxypentyl- and N-aminohexyl-1-deoxy-D-galactonojirimycin were employed for the synthesis of a set of terminally N-dansyl substituted derivatives. Reaction of the terminal carboxylic acid of N-carboxypentyl-1-deoxy-D-galactonojirimycin with N-dansyl-1,6-diaminohexane provided the chain-extended fluorescent derivative. Employing bis(6-dansylaminohexyl)amine, the corresponding branched di-N-dansyl compound was obtained. Partially protected N-aminohexyl-1-deoxy-D-galactonojirimycin served as intermediate for two additional chain-extended fluorescent 1-deoxy-D-galactonojirimycin (1-DGJ) derivatives featuring terminal dansyl groups in the N-alkyl substituent. These new compounds are strong inhibitors of D-galactosidases and may serve as leads en route to pharmacological chaperones for GM1-gangliosidosis. (C) 2011 Published by Elsevier Ltd.
查看更多